MUTYH and cancer: Carriers of germline monoallelic MUTYH pathogenic variants, even when the second hit (e.g., LOH) did not occur, may present haploinsufficiency of the 8-oxoG and create C>A mutations in other tumor suppressors, which may explain an elevated rate of cancer in MUTYH-variant carriers [28].